US industry convenes meeting on FDA's post-market safety progress:
This article was originally published in Clinica
AdvaMed has scheduled a two-day meeting in Bethesda, next month, on the FDA's post-market safety activities. Association officials said the meeting is intended to be a follow-up to a meeting last September on post-market issues involving implantable cardioverter defibrillators and pacemakers. That meeting was organised by the Heart Rhythm Society in the wake of a series of high-profile ICD recalls that led to heightened scrutiny of the industry. The upcoming workshop is scheduled for February 8-9. "It will set the stage for collaboration process improvement initiatives," AdvaMed said, and will be the first in a series of joint post-market workshops with the agency.